Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Takeda patents inhibitors of ICAM-1/ELAM-1 expression for immune, autoimmune disorders

July 20, 1999

Cantab's therapeutic vaccine for genital warts enters phase II trials

July 20, 1999

New topical ciclosporin formulation effective for site-specific immunosuppression

July 20, 1999

Tanox tests Hu-901 in peanut allergy

July 19, 1999

SmithKline Beecham files for approval of first-ever pentavalent vaccine

July 16, 1999

Prophylactic DNA tuberculosis vaccine is also curative in mice

July 16, 1999

Fujisawa launches Prograf in China

July 16, 1999

Pierre Fabre and Rega Institute embark on hantavirus vaccine project

July 15, 1999

Phase I/II data presented for MEDI-507 in steroid-resistant GvHD

July 15, 1999

Oral hepatitis B plant vaccine begins clinical trials in U.S.

July 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...